Form 4: Guardant Health CFO Michael Bell Reports Stock Transactions

Guardant Health's Chief Financial Officer, Michael Bell, executed transactions involving common stock and restricted stock units on January 1, 2025.

Summary

• Michael Bell, the Chief Financial Officer of Guardant Health, engaged in stock transactions on January 1, 2025.
• He acquired 2,084 shares of common stock through the vesting of restricted stock units.
• Additionally, 855 shares were withheld by the company to cover tax obligations related to the vesting.
• The price of the shares withheld for tax purposes was $30.55.
• Following these transactions, Mr. Bell directly owns 26,917 shares of common stock and 14,589 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine filing of insider transactions, which is neither positive nor negative for the company's performance. It is a neutral event.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the stock ownership of key executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The vesting schedule of the restricted stock units, with a portion vesting over three years, is a common practice for executive compensation.
• The tax withholding of shares is also a standard procedure to cover tax obligations related to stock-based compensation.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect the standard vesting of executive compensation.
• The transactions do not have a significant impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Guardant Health, Michael Bell, stock transactions, restricted stock units, Form 4, insider trading, executive compensation